FDA Issues Warning New Hepatitis C Drugs Could Reactivate Hepatitis B Virus

The following is excerpted from an FDA news release. To read the release in its entirety, click here.The U.S. Food and Drug Administration is warning about the risk that some of the new direct-acting antiviral medicines for hepatitis C (HCV) can reactivate the hepatitis B virus (HBV) among patients who have had HBV. “In a few […]

Blood Journal: Analysis of 13 Years of Hemophilia Patient Data

A recent article in Blood, a publication of the American Society of Hematology, examines thirteen years of surveillance data collected by the Centers for Disease Control and Prevention regarding patient outcomes for men with severe hemophilia. Among the key points: Prospectively collected data on demographics, complications, and mortality are described for 4899 US men with […]